Intelicanna Ltd Total Liabilities
Intelicanna Ltd total liabilities. Based on the latest financial reports, Intelicanna Ltd (INTL) has total liabilities worth ILA54.71 Billion ILA (≈ $146.68 Million USD) as of September 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Intelicanna Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Intelicanna Ltd (2012–2022)
Total liabilities of Intelicanna Ltd from 2012 to 2022. This chart illustrates how Intelicanna Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore INTL long-term investment intensity to see how much of total assets are deployed in long-term investments.
Intelicanna Ltd Competitors by Total Liabilities
The table below lists competitors of Intelicanna Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BetterLife Pharma Inc
F:NPAU
|
Germany | €6.04 Million |
|
Gaxos.ai Inc
NASDAQ:GXAI
|
USA | $1.13 Million |
|
Nandani Creation Limited
NSE:JAIPURKURT
|
India | Rs623.08 Million |
|
Biofil Chemicals & Pharmaceuticals Limited
NSE:BIOFILCHEM
|
India | Rs340.59 Million |
|
Adalta Ltd
AU:1AD
|
Australia | AU$2.07 Million |
|
TruCap Finance Limited
NSE:TRU
|
India | Rs3.42 Billion |
|
Bulletin Resources Ltd
AU:BNR
|
Australia | AU$1.23 Million |
|
Balkrishna Paper Mills Limited
NSE:BALKRISHNA
|
India | Rs1.93 Billion |
Liability Composition Analysis (2012–2022)
This chart breaks down Intelicanna Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Intelicanna Ltd's balance sheet.
Liquidity & Leverage Metrics
Intelicanna Ltd Total Liabilities Ratios Explained
Intelicanna Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 22.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 6.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.87 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Intelicanna Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Intelicanna Ltd (2012–2022)
The table below shows the annual total liabilities of Intelicanna Ltd from 2012 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | ILA54.44 Billion ≈ $145.94 Million |
-0.29% |
| 2021-12-31 | ILA54.60 Billion ≈ $146.37 Million |
-6.91% |
| 2020-12-31 | ILA58.65 Billion ≈ $157.24 Million |
+20.61% |
| 2019-12-31 | ILA48.63 Billion ≈ $130.37 Million |
+7.23% |
| 2018-12-31 | ILA45.35 Billion ≈ $121.57 Million |
-0.91% |
| 2017-12-31 | ILA45.76 Billion ≈ $122.68 Million |
+12.69% |
| 2016-12-31 | ILA40.61 Billion ≈ $108.87 Million |
-0.32% |
| 2015-12-31 | ILA40.74 Billion ≈ $109.22 Million |
+1.26% |
| 2014-12-31 | ILA40.23 Billion ≈ $107.86 Million |
+10.55% |
| 2013-12-31 | ILA36.39 Billion ≈ $97.56 Million |
+387.77% |
| 2012-12-31 | ILA7.46 Billion ≈ $20.00 Million |
-- |
About Intelicanna Ltd
Intelicanna Ltd operates as pharmaceutical company in Israel. It grows, cultivates, produces, research, markets, and sells medical cannabis. The company was formerly known as Tefen Industrial Engineering & Management & Systems Analysis and changed its name to Intelicanna Ltd in March 2019. The company was founded in 1981 and is headquartered in Hod Hasharon, Israel.